MERCK KGAA O.N./ DE0006599905 /
2024-03-28 8:16:06 AM | Chg. +1.25 | Volume | Bid6:12:17 PM | Ask6:12:17 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
160.00EUR | +0.79% | 0 Turnover: 0.00 |
163.40Bid Size: 100 | 163.80Ask Size: 100 | 21.2 bill.EUR | 1.34% | 25.27 |
GlobeNewswire
8:00 AM
Intravacc and Primrose Bio Announce Partnership to Enhance Conjugate Vaccine Development
GlobeNewswire
03-04
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
GlobeNewswire
2023-12-21
Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire
2023-12-14
ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
GlobeNewswire
2023-10-17
ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA